Position in EYPT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,185,025
-$896,483 QoQ
Shares Held
152,799
-36.1% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 188 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. EYPT ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in EYPT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,185,025 | 152,799 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $3,081,508 | 239,062 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $4,143,087 | 226,770 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,066,734 | 355,810 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,818,982 | 512,113 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,937,335 | 357,442 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,589,695 | 213,382 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $5,176,304 | 647,848 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $5,511,615 | 633,519 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $17,274,372 | 835,722 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $17,806,323 | 770,503 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $173,893 | 21,764 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $182,125 | 20,934 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $73,205 | 24,900 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $36,424 | 10,407 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $80,935 | 10,232 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $94,243 | 11,975 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $139,153 | 11,453 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $157,100 | 12,835 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,242,373 | 215,199 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,938,118 | 215,586 | Shares | Defined | 2021-08-11 | |
| 2020-06-30 | $1,444 | 1,900 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $21,114 | 20,701 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||